Depression Clinical Trials in Philadelphia

Showing 181-200 of 275 trials

Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication

NCT01277354

The purpose of this study is to examine the effects of experiencing a previous pregnancy loss or complication on current physiological and emotional aspects of a current pregnancy.

Post-traumatic Stress DisorderStress DisordersAnxiety+1 more

University of Pennsylvania2 participantsStarted Apr 2010

Philadelphia, Pennsylvania, United States

COMPLETEDPhase 2< 1 mile

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

NCT01482221

The purpose of this study is to assess the effect and safety of AZD6765 in patients with major depressive disorder who exhibit inadequate response to antidepressants. AZD6765 is a channel blocker of the N-methyl-D-aspartate (NMDA) class of glutamate receptors.

Major Depressive Disorder

AstraZeneca542 participantsStarted Dec 2011

Chino, California, United States • Lond Beach, California, United States • San Diego, California, United States +41 more locations

Effectiveness of Cognitive Processing Therapy in Pregnant Women With a History of Pregnancy Loss/Complication

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Depression Trials in Other Cities

Depression in Alzheimer's Disease-2

Treatment for Depression Among HIV-Infected Youth

Treatment for Depressed, Obese Individuals at Risk for Cardiovascular Disease (CVD)

Participatory Design of Patient-centered Depression and Diabetes Care

Mobile App for Mood in Pregnancy (Ginger iO)

Enhancing Parenting for Depressed Caregivers

Major Depressive Disorder With Mixed Features - Extension

Combination Chemotherapy Plus Fluoxetine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Lurasidone - A 24-week Extension Study of Patients With Bipolar I Depression

Mental Health Services for Foster and Adopted Children

Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

Brexpiprazole (OPC-34712) as an Adjunctive Treatment in Adults With Major Depressive Disorder and Anxiety Symptoms

An Eight-week Study of Saredutant and Escitalopram as Combination Treatment for Major Depressive Disorder

Process and Outcomes in CBT for Anxious and Depressed Youth

Prolonging Remission in Depressed Elderly (PRIDE)

A Study Of DVS SR In Treatment Of Children And Adolescent Outpatients With MDD

Early Detection and Intervention for the Prevention of Psychosis

Safety Study of Ziprasidone (Geodon) for the Depressive Mixed State

Other Conditions in Philadelphia